These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 16117399

  • 21. [Curative effect of transtympanic perfusion of gentamicin on unilateral Ménière's disease].
    Nie GH, Lu YD.
    Zhonghua Yi Xue Za Zhi; 2003 Aug 10; 83(15):1356-8. PubMed ID: 12930695
    [Abstract] [Full Text] [Related]

  • 22. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul 10; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 23. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N, Boleas MS, Martin E.
    Audiol Neurootol; 2005 Jul 10; 10(2):69-78. PubMed ID: 15650298
    [Abstract] [Full Text] [Related]

  • 24. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP, Din S, Atlas MD.
    J Laryngol Otol; 2005 May 10; 119(5):391-5. PubMed ID: 15949105
    [Abstract] [Full Text] [Related]

  • 25. [Transtympanic gentamicin in Ménière's disease: evaluation of the quality of life].
    Comacchio F, Martinez-Monche G, Chiappetta A, Fernandez S, Staffieri A.
    Acta Otorhinolaryngol Ital; 2001 Apr 10; 21(2):71-6. PubMed ID: 22111129
    [Abstract] [Full Text] [Related]

  • 26. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo.
    Carey J.
    Otolaryngol Clin North Am; 2004 Oct 10; 37(5):1075-90. PubMed ID: 15474112
    [Abstract] [Full Text] [Related]

  • 27. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T.
    Otol Neurotol; 2006 Sep 10; 27(6):896-900. PubMed ID: 16788414
    [Abstract] [Full Text] [Related]

  • 28. [Intratympanic gentamicin treatment for intractable Menière's disease].
    Gilony D, Wolf M, Kronenberg J.
    Harefuah; 2004 Jan 10; 143(1):4-7, 88. PubMed ID: 14748278
    [Abstract] [Full Text] [Related]

  • 29. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V, Carner M, Colletti L.
    Otol Neurotol; 2007 Feb 10; 28(2):145-51. PubMed ID: 17255880
    [Abstract] [Full Text] [Related]

  • 30. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
    Smith WK, Sandooram D, Prinsley PR.
    J Laryngol Otol; 2006 Sep 10; 120(9):730-5. PubMed ID: 16848921
    [Abstract] [Full Text] [Related]

  • 31. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E, Aidonis I, Sismanis A.
    J Laryngol Otol; 2009 Apr 10; 123(4):379-82. PubMed ID: 18954493
    [Abstract] [Full Text] [Related]

  • 32. Transtympanic steroids for Ménière's disease.
    Herraiz C, Plaza G, Aparicio JM, Gallego I, Marcos S, Ruiz C.
    Otol Neurotol; 2010 Jan 10; 31(1):162-7. PubMed ID: 19924013
    [Abstract] [Full Text] [Related]

  • 33. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E, Perez N.
    Otol Neurotol; 2003 Sep 10; 24(5):800-6. PubMed ID: 14501459
    [Abstract] [Full Text] [Related]

  • 34. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE, Kamerer DB.
    Am J Otol; 1997 Jan 10; 18(1):44-51. PubMed ID: 8989951
    [Abstract] [Full Text] [Related]

  • 35. Intratympanic gentamicin treatment for unilateral Ménière's disease: long-term follow up of a proven regime.
    Wasson J, Upile N, Pfleiderer A.
    J Laryngol Otol; 2013 Jan 10; 127(1):20-4. PubMed ID: 23217984
    [Abstract] [Full Text] [Related]

  • 36. Use of the round window microcatheter in the treatment of Meniere's disease.
    Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D, Balaban C.
    Laryngoscope; 2001 Nov 10; 111(11 Pt 1):2046-9. PubMed ID: 11801994
    [Abstract] [Full Text] [Related]

  • 37. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M, Marsan J, Schramm D, Robichaud J.
    J Otolaryngol; 1997 Dec 10; 26(6):361-4. PubMed ID: 9438932
    [Abstract] [Full Text] [Related]

  • 38. Long-term results of gentamicin inner ear perfusion in Ménière's disease.
    Suryanarayanan R, Cook JA.
    J Laryngol Otol; 2004 Jul 10; 118(7):489-95. PubMed ID: 15318953
    [Abstract] [Full Text] [Related]

  • 39. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS, Sánchez-Ferrandiz N, Guillén-Grima F, Perez N.
    Laryngoscope; 2007 Aug 10; 117(8):1474-81. PubMed ID: 17607149
    [Abstract] [Full Text] [Related]

  • 40. Middle ear exploration in patients with Ménière's disease who have failed outpatient intratympanic gentamicin therapy.
    Crane BT, Minor LB, Della Santina CC, Carey JP.
    Otol Neurotol; 2009 Aug 10; 30(5):619-24. PubMed ID: 19503016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.